We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

13 hedge funds and large institutions have $4.12M invested in Anixa Biosciences in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

55% more capital invested

Capital invested by funds: $2.65M → $4.12M (+$1.47M)

0.02% more ownership

Funds ownership: 4.73% → 4.75% (+0.02%)

13% less funds holding

Funds holding: 15 → 13 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
7
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$352K
2
BlackRock
BlackRock
New York
+$24.7K
3
Wells Fargo
Wells Fargo
California
+$24.5K
4
Northern Trust
Northern Trust
Illinois
+$18.7K
5
JP Morgan Chase
JP Morgan Chase
New York
+$8.82K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$265K
2
CAM
Concorde Asset Management
Michigan
-$30K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$6.2K
4
TRCT
Tower Research Capital (TRC)
New York
-$5.83K
5
Morgan Stanley
Morgan Stanley
New York
-$3.55K

ANIX Hedge Fund Activity: Q3 2018 in Review

13 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2018, worth a combined $4.12M — up 55% from $2.65M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ANIX and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was UBS Group, adding an estimated $352K. The largest seller was Geode Capital Management, exiting entirely with an estimated $265K sold.

  • 13 institutional investors held Anixa Biosciences (ANIX) as of Q3 2018, down from 15 in Q2 2018.
  • Funds reported $4.12M of Anixa Biosciences stock for Q3 2018, up 55% quarter-over-quarter.
  • 0 funds opened new Anixa Biosciences positions in Q3 2018 and 2 closed out, a net change of -2 holders.
  • The largest Anixa Biosciences buyer in Q3 2018 was UBS Group, an estimated $352K added.
  • The largest Anixa Biosciences seller in Q3 2018 was Geode Capital Management, an estimated $265K sold.

Based on aggregated 13F filings for Q3 2018.